1Kool M,van der Linden M,de Haas M,et al.MRP3,an organic anion transporter able to transport anti - cancer drugs [J].Proc Natl Acad Sci USA,1999;96(12) :6914 - 6919.
2Young LC,Campling BG,Voskoglou - Nomikos T,et al.Expressionof multidrug resistance protein - related genes in lung cancer:correlation with drug response [J].Clin Cancer Res,1999;5(3) :673 - 680.
3Qka M,Fukuda M,Sakamoto A,et al.The clinical role of MDR1 gene expression in human lung cancer [J].Anticancer Res,1997;179(1):721 - 724.
5Cole SP,Deeley RG.Multidrug resistance mediated by the ATPbinding cassette transporter protein MRP [J].Bioessays,1998; 20(11) :931 -940.
6Oshika Y,Nakamura M,Tokunaga T,et al.Multidrug resistance - associated protein and mutant p53 protein expression in non- small - cell lung cancer [J].Mod Pathol,1998;11(11):1059- 1063.
7Kawabata S,Oka M,Shiozawa K,et al.Breast cancer resistance protein directly confers SN - 38 resistance of lung cancer cells.Biochem Biophys Res Commun,2001;280:1216 - 1223.
8Sandri MI,Hochhauser D,Ayton P,et al.Differential expression of the topoisomerase Ⅱα and β genes in human breast cancers [J].Br J Cancer,1996 ;73:1518 - 1524.
9Filipits M,Stranzl T,Phol G,et al.Clinical relevance of the lung resistance protein in diffuse large B - cell lymphomas [J].Drug Clin Cancer Res,2000;6:3417 - 3423.
10Berger W,Elbling L,Micksche M.Expression of the major vault protein LRP in human non - small - cell lung cancer cells:activation by short- trem exposure to antineoplastic drugs [J].Int J Cancer,2000;88(2) :293 - 300.
二级参考文献14
1曹治权.微量元素与中医药[M].中国中医药出版社,1996,2..
2West AK, Stallings R, Hildebrand CE, et al. Human metallothionein genes:structure of the functional locus at 16q13. Genomics, 1990, 8 (3): 513-518
3Hart BA, Voss GW, Vacek PM, et al. Metallothionein in human lung carcinoma. Cancer Lett, 1993, 75: 121-128
4Kasutani K, Itoh N, Kanekiyo M, et al. Requirement for cooperative interaction of interleukin-6 responsive element type 2 and glucocorticoid responsive element in the synergistic activation of mouse metallothionein-1 gene by interleukin-6 and glucocorticoid. Toxicol Appl Pharmacol, 1998, 151: 143-151
5Dalton T, Palmiter RD, Andrews GK, et al. Transcriptional induction of the mouse metallothionein-1 gene in hydrogen peroxide-treated hepa cells involves a composite major late transcription factor/antioxidant response element and mental response promotor elements. Nucleic Acids Res, 1994, 22: 5016-5023
6Giuffre G, Barresi G, Sturniolo GC, et al. Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas, and in adenocarcinomas and their associated metastases. Histopathology, 1996, 29:347-354
7Bahnson RR, Banner BF, Ernstoff MS, et al. Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol, 1991, 146: 1518-1520
8Jin R, Chow VTK, Hoon P, et al. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis, 2002, 23 (1): 81-86
9McCluggage WG, Maxwell P, Hamilton PW, et al. High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology, 1999, 34: 51-55
10Jin R, Bay BH, Chow VTK, et al. Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma. Breast cancer Res Treat, 2001, 66: 265-272
